Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Meningioma × Tranexamic Acid × Clear all

Phase

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hemorrhage 6 Leiomyoma 3 Hematologic Neoplasms 3 Urinary Bladder Neoplasms 2 Seizures 2 Postoperative Hemorrhage 2 Ovarian Neoplasms 2 Neoplasms 2 Menorrhagia 2 Urologic Diseases 1 Urinary Tract Infections 1 Urinary Retention 1 Thromboembolism 1 Thrombocytopenia 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Seroma 1 Sepsis 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pneumonia 1 Patient Satisfaction 1 Pain 1 Neutropenia 1

Interventions

Hydroxyurea 4 Imatinib Mesylate 3 Everolimus 3 aldesleukin 2 Temozolomide 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2 Proton Therapy 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Laser Speckle Contrast Imaging 2 Filgrastim 2 Donepezil 2 Cyclophosphamide 2 Carmustine 2 Bortezomib 2 Bevacizumab 2 Aminolevulinic Acid 2 90Y-octreotide, DOTA-Tyr(3)- 2 vatalanib 1 trametinib 1 tozuleristide 1 temsirolimus 1 sonidegib 1 sargramostim 1 ribociclib 1 gallium Ga 68 dotatate 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04595786 2025-03-04

STAMP

Beijing Tiantan Hospital

Phase NA Completed

Meningioma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡